EDWARDS LIFESCIENCES CORPORATION Edwards Lifesciences Corporation Stock Xetra
Equities
EWL
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.02 EUR | -1.39% |
|
-1.04% | +15.60% |
| Apr. 29 | Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72 | MT |
| Apr. 26 | Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 | MT |
| Sales 2024 * | 6.56B 6.12B | Sales 2025 * | 7.2B 6.72B | Capitalization | 51.74B 48.28B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.63B 1.52B | Net income 2025 * | 1.86B 1.73B | EV / Sales 2024 * | 7.64 x |
| Net cash position 2024 * | 1.65B 1.54B | Net cash position 2025 * | 2.84B 2.65B | EV / Sales 2025 * | 6.79 x |
| P/E ratio 2024 * |
31.9
x | P/E ratio 2025 * |
28
x | Employees | 19,800 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.59% |
More Fundamentals
* Assessed data
More news
Latest transcript on Edwards Lifesciences Corporation
More recommendations
More press releases
More news
| 1 day | -1.39% | ||
| 1 week | -1.04% | ||
| Current month | -9.27% | ||
| 1 month | -9.27% | ||
| 3 months | +16.95% | ||
| 6 months | +36.55% | ||
| Current year | +15.60% |
1 week
79.95
82.57
1 month
79.9588.22
Current year
65.9088.64
1 year
57.3888.64
3 years
57.38119.58
5 years
57.38119.58
10 years
57.38119.58
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 14-12-31 | |
| Chairman | 71 | 99-12-31 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 13-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 16-07-04 |
| Director/Board Member | 67 | 14-11-12 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 80.02 | -1.39% | 1,055 |
| 24-04-26 | 81.15 | -0.81% | 1,055 |
| 24-04-25 | 81.81 | -0.92% | 340 |
| 24-04-24 | 82.57 | +1.19% | 102 |
| 24-04-23 | 81.6 | +0.92% | 239 |
Delayed Quote Xetra, April 29, 2024 at 11:35 am EDT
More quotes
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-05-07
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
85.95
USD
Average target price
95.38
USD
Spread / Average Target
+10.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.69% | 219B | |
| +6.69% | 183B | |
| +10.90% | 133B | |
| +25.41% | 108B | |
| +0.27% | 63.06B | |
| +3.96% | 48.2B | |
| +0.40% | 40.37B | |
| +15.03% | 39.35B | |
| +26.26% | 32.03B |
- Stock Market
- Equities
- EW Stock
- EWL Stock
